Skip to main content

Assistant Professor

Areas of Interest

Non-malignant hematology, primarily bleeding disorders and sickle cell disease.


I am interested in the interaction between endothelium and coagulation proteins as well as blood cells. I have recently presented data showing an increase of factor Xa generation on endothelium in the presence of emicizumab and factor IXa. I am active in investigating the mechanism of thrombosis and thrombotic microangiopathy in the use of emicizumab and have an interest in improving the treatment of breakthrough bleeding in patients on emicizumab. I am more generally interested in the development of systems that can shed light on the mechanisms and complications of emerging, non-factor therapies for hemophilia.

Education and Training

  • UndergraduateUniversity of Utah
  • Medical SchoolThe Ohio State University
  • ResidencyUniversity of Rochester Medical Center
  • FellowshipUniversity of North Carolina Hospitals, Pediatric Hematology and Oncology
  • FellowshipUniversity of North Carolina Hospitals, Medical Hematology



  • Address

    116 Manning Drive


    Chapel Hill, NC 27514